-
ANDA Approvals - New Drug Applications and 505(b)(2) Applications: Third Quarter
15 Nov 2024 22:16 GMT
Approval Date
Reference Listed Drug
Generic Drug Name
NDA Holder
ANDA …
Endari
L-Glutamine
Emmaus Medical
Novitium Pharma
215647
07… #47;16/2024
Tykerb
Lapatinib Ditosylate
Novartis
Teva
… 2024
Tarceva
Erlotinib HCl
OSI Pharmaceuticals
Hikma
203843
09…
-
Gupta Discusses T-DM1’s Role in HER2+ Breast Cancer Treatment
23 Oct 2024 02:10 GMT
… University Department of Medicine, Division of Medical Oncology, discusses the … , was the first antibody-drug conjugate (ADC) to be … remains a mainstay of treatment for patients with HER2- … and lapatinib [Tykerb] as based on the EMILIA trial [NCT00829166]. And …
-
Less Toxic, More Personalized Treatments on the Horizon in HER2+ Breast Cancer
12 Sep 2024 22:52 GMT
… ,” shared Dempsey, breast medical oncologist at Baptist Health … approaches, less toxic treatments, promising trial results, and more. … that reason, ongoing trials are evaluating treatments with CNS activity … [Nerlynx] and lapatinib [Tykerb] caused a lot more …
-
Breast Cancer Screening and Treatment Update
18 Sep 2024 16:27 GMT
… drugs, primarily targeted therapies, have recently been FDA approved for treatment … Pharmaceuticals LP; November 2023.
28. Tykerb (lapatinib) product … Pharmaceutical Corp; March 2022.
29. Nerlynx (neratinib) product information. Los Angeles, CA: Puma Biotechnology …
-
Pfizer gets selling right of targeted breast cancer drug Tukysa, but domestic release is uncertain
20 Aug 2024 03:54 GMT
… the Korean breast cancer treatment market.
Tukysa, developed … there is Novartis' Tykerb (lapatinib), which has been … Korea.
In response, Korean doctors have used BIXINK… Tukysa.
However, according to pharmaceutical sources, Pfizer is reportedly …
-
Strategies for the Management of Relapsed/Refractory Metastatic Colorectal Cancer: From Landmark Trials to Precision Medicine
11 Jul 2024 22:55 GMT
… in clinical trials that led to FDA approval. … treatment itself, an additional consideration for precision medicine … . Prescribing information. Taiho Pharmaceutical; 2023. Accessed April … perjeta_prescribing.pdf
32. Tykerb. Prescribing information. Novartis; …
-
Infinant Health Appoints New Team Members to assist with Drug Development
22 May 2024 10:19 GMT
… human clinical trials, coupled with their profound pharmaceutical knowledge, … Cornell University, her Doctor of Medicine degree from The … Altabax) and oncology (Tykerb, Votrient, Promacta) drugs. As Owner of … roles at global biotechnology leader Amgen, most …
-
25 drugs at Mark Cuban's online pharmacy with biggest cost reductions
06 Apr 2024 00:30 GMT
… Drugs now sells hundreds of generics and about 20 branded medications … pharmacy benefit managers.
Each drug is priced at its … medications with the biggest price cuts sold at Cost Plus Drugs … 50
Lapatinib ditosylate (generic for Tykerb)
Retail price: $4,353 …
-
Combining Drugs and Radiation in Breast Cancer: What's Safe?
14 Mar 2024 11:02 GMT
Targeted treatments, including antibody-drug conjugates and … School of Medicine, Indianapolis, Indiana.
If trials evaluating … radiotherapy in clinical trial setting
PARP inhibitors … drugs trastuzumab (Herceptin), pertuzumab (Perjeta), and lapatinib (Tykerb) …
-
Advancing Pharmacists’ Role in Personalized Treatment for Breast, Prostate, and Lung Cancer
22 Feb 2024 14:19 GMT
… treatments to minimize adverse reactions. The labeling of many FDA-approved anticancer drugs … Genentech), and lapatinib (Tykerb; GSK), each targeting … of precision oncology trials: challenges and … and precision medicine. Trends Biotechnol. 2020;38 …